IL212960A0
Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
112 members in 33 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 12027508 | United States of America | P | |
| 18118009 | United States of America | P | |
| 2009066790 | United States of America | W |
Members112
| Document | Office | Kind | |
|---|---|---|---|
| AU2009322219A1 | Australia | A1 | |
| CA2744711A1 | Canada | A1 | |
| WO2010065865A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2010152183A1 | United States of America | A1 | |
| UY32305A | Uruguay | A | |
| TW201029992A | Taiwan Province of China | A | |
| WO2010065865A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2010298321A1 | United States of America | A1 | |
| AR074510A1 | Argentina | A1 | |
| UY32680A | Uruguay | A | |
| CA2778586A1 | Canada | A1 | |
| WO2011068561A1 | World Intellectual Property Organization (WIPO) | A1 | |
| MX2011005922A | Mexico | A | |
| TW201120033A | Taiwan Province of China | A | |
| AR076945A1 | Argentina | A1 | |
| IL212960A0This record | Israel | A0 | |
| KR20110103406A | Republic of Korea | A | |
| EP2376480A2 | European Patent Office (EPO) | A2 | |
| CR20110351A | Costa Rica | A | |
| CN102307872A | China | A | |
| CO6390038A2 | Colombia | A2 | |
| ZA201103806B | South Africa | B | |
| JP2012511020A | Japan | A | |
| AU2010326728A1 | Australia | A1 | |
| MX2012006378A | Mexico | A | |
| SG181491A1 | Singapore | A1 | |
| IL220129A0 | Israel | A0 | |
| HK1162031A | Hong Kong, China | A | |
| HK1162031A1 | Hong Kong, China | A1 | |
| CR20120346A | Costa Rica | A | |
| EP2507229A1 | European Patent Office (EPO) | A1 | |
| KR20120135199A | Republic of Korea | A | |
| CO6592044A2 | Colombia | A2 | |
| RU2011127402A | Russian Federation | A | |
| CN102947285A | China | A | |
| JP2013512900A | Japan | A | |
| AU2009322219B2 | Australia | B2 | |
| HK1177201A | Hong Kong, China | A | |
| HK1177201A1 | Hong Kong, China | A1 | |
| AU2013211540A1 | Australia | A1 | |
| NZ592801A | New Zealand | A | |
| US8563735B2 | United States of America | B2 | |
| US2013296295A1 | United States of America | A1 | |
| RU2497822C2 | Russian Federation | C2 | |
| US8586754B2 | United States of America | B2 | |
| RU2012127760A | Russian Federation | A | |
| US2014057889A1 | United States of America | A1 | |
| US2014057890A1 | United States of America | A1 | |
| US2014107119A1 | United States of America | A1 | |
| NZ599778A | New Zealand | A | |
| JP5591347B2 | Japan | B2 | |
| UA106640C2 | Ukraine | C2 | |
| AU2010326728B2 | Australia | B2 | |
| RU2013133800A | Russian Federation | A | |
| UA107655C2 | Ukraine | C2 | |
| RU2542994C2 | Russian Federation | C2 | |
| JP5684720B2 | Japan | B2 | |
| NZ614305A | New Zealand | A | |
| SG10201500767RA | Singapore | A | |
| US9045420B2 | United States of America | B2 | |
| US9072748B2 | United States of America | B2 | |
| US9073855B2 | United States of America | B2 | |
| JP2015129134A | Japan | A | |
| CN102947285B | China | B | |
| US9125913B2 | United States of America | B2 | |
| TW201538482A | Taiwan Province of China | A | |
| UA110170C2 | Ukraine | C2 | |
| AU2013211540B2 | Australia | B2 | |
| US2016009687A1 | United States of America | A1 | |
| TWI522354B | Taiwan Province of China | B | |
| US9315488B2 | United States of America | B2 | |
| EP2376480B1 | European Patent Office (EPO) | B1 | |
| CN102307872B | China | B | |
| KR101638804B1 | Republic of Korea | B1 | |
| IL245889A0 | Israel | A0 | |
| CR20160269A | Costa Rica | A | |
| DK2376480T3 | Denmark | T3 | |
| LT2376480T | Lithuania | T | |
| IL212960A | Israel | A | |
| EP2507229B1 | European Patent Office (EPO) | B1 | |
| CN106008322A | China | A | |
| HRP20161085T1 | Croatia | T1 | |
| PT2376480T | Portugal | T | |
| MX343216B | Mexico | B | |
| SI2376480T1 | Slovenia | T1 | |
| ES2588374T3 | Spain | T3 | |
| JP6034412B2 | Japan | B2 | |
| MY158932A | Malaysia | A | |
| EP3101019A1 | European Patent Office (EPO) | A1 | |
| PL2376480T3 | Poland | T3 | |
| KR101692705B1 | Republic of Korea | B1 | |
| KR20170007486A | Republic of Korea | A | |
| RS55176B1 | Serbia | B1 | |
| HUE029289T2 | Hungary | T2 | |
| ES2609607T3 | Spain | T3 | |
| RU2621052C2 | Russian Federation | C2 | |
| CA2744711C | Canada | C | |
| IL220129A | Israel | A | |
| TWI600642B | Taiwan Province of China | B | |
| TWI600652B | Taiwan Province of China | B |
Showing 100 of 112
3 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF |
Numbers
- Application
- 212960
Titles
- English
- SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES
Classification
- CPC, 71
- C07D211/58
- C07D295/14
- C07D405/12
- C07D209/08
- C07D209/20
- C07D209/32
- C07D211/96
- C07D213/64
- C07D215/14
- C07D215/20
- C07D217/16
- C07D231/56
- C07D235/26
- C07D241/04
- C07D249/04
- C07D295/125
- C07D295/13
- C07D295/155
- C07D309/04
- C07D309/08
- C07D309/14
- C07D309/32
- C07D401/06
- C07D401/12
- C07D403/06
- C07D405/06
- C07D405/14
- C07D413/06
- C07D417/12
- C07D471/04
- C07D487/04
- A61P1/04
- A61P1/16
- A61P11/00
- A61P11/02
- A61P11/06
- A61P15/00
- A61P17/00
- A61P17/06
- A61P17/14
- A61P19/02
- A61P21/04
- A61P25/00
- A61P25/06
- A61P25/14
- A61P25/16
- A61P25/28
- A61P27/02
- A61P29/00
- A61P31/00
- A61P31/04
- A61P31/12
- A61P33/00
- A61P35/00
- A61P35/02
- A61P37/00
- A61P37/06
- A61P37/08
- A61P43/00
- A61P5/00
- A61P7/00
- A61P7/06
- A61P9/00
- A61P9/10
- A61P9/12
- A61K31/496
- A61K31/501
- C07D295/12
- A61K31/453
- A61K31/46
- A61K31/5377